Your browser doesn't support javascript.
loading
Surgery versus botulinum neurotoxin A to reduce drooling and improve daily life for children with neurodevelopmental disabilities: a randomized controlled trial.
Bekkers, Stijn; Pruijn, Ineke M J; van der Burg, Jan J W; van Hulst, Karen; Kok, Saskia E; Delsing, Corinne P; Scheffer, Arthur R T; van den Hoogen, Frank J A.
Afiliação
  • Bekkers S; Department of Otorhinolaryngology and Head and Neck Surgery, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Pruijn IMJ; Department of Otorhinolaryngology and Head and Neck Surgery, Radboud University Medical Center, Nijmegen, the Netherlands.
  • van der Burg JJW; Department of Pediatric Rehabilitation, Sint Maartenskliniek, Nijmegen, the Netherlands.
  • van Hulst K; School of Pedagogical and Educational Science, Radboud University, Nijmegen, the Netherlands.
  • Kok SE; Department of Rehabilitation, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, the Netherlands.
  • Delsing CP; Department of Otorhinolaryngology and Head and Neck Surgery, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Scheffer ART; Department of Otorhinolaryngology and Head and Neck Surgery, Radboud University Medical Center, Nijmegen, the Netherlands.
  • van den Hoogen FJA; Department of Otorhinolaryngology and Head and Neck Surgery, Radboud University Medical Center, Nijmegen, the Netherlands.
Dev Med Child Neurol ; 63(11): 1351-1359, 2021 11.
Article em En | MEDLINE | ID: mdl-33997959
ABSTRACT

AIM:

To compare the effect of bilateral submandibular duct ligation and botulinum neurotoxin A (BoNT-A) on drooling severity and its impact on daily life and care in children and adolescents with moderate-to-severe drooling.

METHOD:

This was a randomized, interventional, controlled trial in which 53 children and adolescents (31 males, 22 females, mean age 11y, range 8-22y, SD 2y 10mo) with cerebral palsy (58.5%) or other non-progressive developmental disorders (41.5%) were randomized to BoNT-A (n=26) or bilateral submandibular duct ligation (n=27). A parent questionnaire on the severity of drooling in specific positions and daily activities and the impact of drooling on daily life and care was filled out at baseline and 8 and 32 weeks posttreatment.

RESULTS:

Both BoNT-A and bilateral submandibular duct ligation had a positive effect on daily care, damage to electronic equipment and/or furniture, social interactions, and self-esteem. However, bilateral submandibular duct ligation had a significant greater and longer-lasting short- (8wks) and medium-term (32wks) effect on daily care, reducing damage to electronic devices, and improving social interactions and satisfaction with life in general.

INTERPRETATION:

This randomized controlled trial confirms reduced drooling by both BoNT-A and bilateral submandibular duct ligation, but provides new evidence on improved well-being through a reduction in drooling. Even though there is a greater risk of complications and morbidity after bilateral submandibular duct ligation, compared to BoNT-A there was a significantly greater and longer-lasting positive effect on most outcomes. What this paper adds Bilateral botulinum neurotoxin A (BoNT-A) and submandibular duct ligation had a positive effect on the well-being of individuals with moderate-to-severe drooling. Bilateral submandibular duct ligation had a greater effect on the impact of drooling during daily care than BoNT-A. Bilateral submandibular duct ligation reduced damage to electronic devices and improved social interactions and satisfaction with life.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Sialorreia / Deficiências do Desenvolvimento / Ductos Salivares / Toxinas Botulínicas Tipo A Tipo de estudo: Clinical_trials Aspecto: Patient_preference Limite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Revista: Dev Med Child Neurol Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Sialorreia / Deficiências do Desenvolvimento / Ductos Salivares / Toxinas Botulínicas Tipo A Tipo de estudo: Clinical_trials Aspecto: Patient_preference Limite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Revista: Dev Med Child Neurol Ano de publicação: 2021 Tipo de documento: Article